![](https://www.longwoodfund.com/wp-content/uploads/2018/10/millendo-banner.jpg)
Millendo Therapeutics is leveraging novel biological insights to create transformative therapeutics for patients suffering from endocrine disorders of significant unmet need, including Prader-Willi syndrome, congenital adrenal hyperplasia, and endogenous Cushing’s syndrome.